Today: 4 July 2026
Brookdale Senior Living stock jumps on early 2025 results and fresh 2026 outlook ahead of Investor Day
29 January 2026
1 min read

Brookdale Senior Living stock jumps on early 2025 results and fresh 2026 outlook ahead of Investor Day

New York, Jan 29, 2026, 14:54 EST — Regular session

  • BKD shares have jumped roughly 11% following preliminary 2025 results and updated guidance for 2026
  • Brookdale projects adjusted EBITDA between $502 million and $516 million for 2026, alongside RevPAR growth of 8% to 9%
  • Rising price targets on Wall Street are shining a brighter spotlight on management’s Investor Day set for Jan. 30

Shares of Brookdale Senior Living Inc climbed almost 11% Thursday, building on earlier gains following the release of preliminary 2025 results and the company’s inaugural full-year forecast for 2026. The stock hit $14.55, up 10.9%, reaching an intraday peak of $14.62.

This matters because Brookdale is rolling out 2026 figures just a day ahead of its Investor Day, giving a fast snapshot of whether gains in senior-housing prices are feeding through to operating profit and cash flow. Investors have been eager for a sharper link between portfolio moves and management’s forward targets.

It’s entering a market that swiftly penalizes weak cash flow. Non-GAAP profit numbers might look better, but working capital shifts and transaction timing can drag cash the opposite way. Brookdale, meanwhile, has been relying on steadily reducing its leverage.

Late Wednesday, Brookdale projected 2025 revenue around $3.2 billion, with adjusted EBITDA hitting about $458 million—up roughly 19% from 2024 and above the midpoint of its earlier forecast. The company also anticipates a 2025 net loss near $263 million, which includes roughly $71 million in non-cash impairment charges mainly linked to planned asset sales. Adjusted free cash flow will fall short of the previous $30 million to $50 million range due to working-capital shifts. Looking ahead to 2026, Brookdale expects RevPAR growth between 8% and 9%, with adjusted EBITDA between $502 million and $516 million. CEO Nick Stengle commented, “We are pleased with the progress we made in 2025,” and repeated the target to bring leverage below 6.0x by the end of 2028. PR Newswire

Analysts wasted no time. BofA Securities lifted its price target to $15.50 from $13 and maintained a Buy rating, noting Brookdale’s 2026 guidance midpoint sits about 4% above consensus estimates.

RBC Capital raised its price target to $17 from $13, keeping an Outperform rating, according to a GuruFocus report citing analyst Ben Hendrix.

RevPAR — revenue per available unit — measures pricing and occupancy in senior housing. Adjusted EBITDA serves as a stand-in for operating profit before interest, taxes, depreciation, and amortization, with adjustments for specific items. Traders will watch Brookdale’s 2026 guidance closely, gauging if the company can keep raising rates without those gains being eroded by rising costs.

There’s potential for disappointment. These numbers are preliminary and unaudited. Brookdale warned results might shift as the year-end process wraps up. The gap in adjusted free cash flow compared to earlier guidance also shows how fast working capital can fluctuate, even with EBITDA on the rise.

Brookdale’s Investor Day webcast is set for Friday, Jan. 30, at 9:00 a.m. CT (10:00 a.m. ET). Investors will be focused on updates around transaction activity, the 2026 bridge, and if management’s leverage strategy remains viable given actual cash flow.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Rolls-Royce Flags Defence Spending Tailwind, Bombardier Tie-Up and Board Changes
    July 3, 2026, 9:31 PM EDT. Rolls-Royce Holdings (LSE:RR.) is set to benefit from a boost in UK government defence spending, with focus on advanced warfare and propulsion tech. The company points to upside for its defence engines and support projects. Rolls-Royce struck a deal with Bombardier to step up aircraft engine monitoring. The board is bringing in new non-executive directors to strengthen governance. The stock is up 25.7% for the year, sitting 5.1% above analysts' targets and running 58.7% above estimated fair value, making valuation look stretched. Forecasts point to earnings dropping by 3.1% a year over the next three years, putting sustainability of recent gains in question. Investors are watching how defence contracts, the Bombardier partnership, and board moves will hit revenue, margins, and cash flow.
Dow Jones today: DJIA edges up near 49,000 as AI spending scrutiny deepens
Previous Story

Dow Jones today: DJIA edges up near 49,000 as AI spending scrutiny deepens

Accenture stock slides 3% as new share award pool wins approval — what investors watch next
Next Story

Accenture stock slides 3% as new share award pool wins approval — what investors watch next

Go toTop